192 related articles for article (PubMed ID: 24932473)
21. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
[TBL] [Abstract][Full Text] [Related]
23. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer.
D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK
Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006
[TBL] [Abstract][Full Text] [Related]
24. Disruption of aryl hydrocarbon receptor homeostatic levels during embryonic stem cell differentiation alters expression of homeobox transcription factors that control cardiomyogenesis.
Wang Q; Chen J; Ko CI; Fan Y; Carreira V; Chen Y; Xia Y; Medvedovic M; Puga A
Environ Health Perspect; 2013; 121(11-12):1334-43. PubMed ID: 24058054
[TBL] [Abstract][Full Text] [Related]
25. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.
Wang CK; Chang H; Chen PH; Chang JT; Kuo YC; Ko JL; Lin P
Int J Cancer; 2009 Aug; 125(4):807-15. PubMed ID: 19358281
[TBL] [Abstract][Full Text] [Related]
26. Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells.
Jin UH; Lee SO; Safe S
J Pharmacol Exp Ther; 2012 Nov; 343(2):333-41. PubMed ID: 22879383
[TBL] [Abstract][Full Text] [Related]
27. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
28. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
29. Invasion and migration of MDA-MB-231 cells are inhibited by block of AhR and NFAT: role of AhR/NFAT1/β4 integrin signaling.
Shadboorestan A; Tarfiei GA; Montazeri H; Sepand MR; Zangooei M; Khedri A; Ostad SN; Ghahremani MH
J Appl Toxicol; 2019 Feb; 39(2):375-384. PubMed ID: 30294794
[TBL] [Abstract][Full Text] [Related]
30. Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S; Kim K; Jin UH; Pfent C; Cao H; Amendt B; Liu X; Wilson-Robles H; Safe S
Mol Cancer Ther; 2012 Jan; 11(1):108-18. PubMed ID: 22034498
[TBL] [Abstract][Full Text] [Related]
31. Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).
Wong PS; Li W; Vogel CF; Matsumura F
BMC Cancer; 2009 Jul; 9():234. PubMed ID: 19604390
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
Zhou L; Gao HF; Liu DS; Feng JY; Gao DD; Xia W
Gene; 2018 Jan; 640():21-27. PubMed ID: 29024707
[TBL] [Abstract][Full Text] [Related]
33. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells.
Piwarski SA; Thompson C; Chaudhry AR; Denvir J; Primerano DA; Fan J; Salisbury TB
Biochem Pharmacol; 2020 Apr; 174():113845. PubMed ID: 32032581
[TBL] [Abstract][Full Text] [Related]
34. Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
Peng TL; Chen J; Mao W; Song X; Chen MH
BMC Cell Biol; 2009 Apr; 10():27. PubMed ID: 19371443
[TBL] [Abstract][Full Text] [Related]
35. Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression.
Vogel CF; Li W; Wu D; Miller JK; Sweeney C; Lazennec G; Fujisawa Y; Matsumura F
Arch Biochem Biophys; 2011 Aug; 512(1):78-86. PubMed ID: 21640702
[TBL] [Abstract][Full Text] [Related]
36. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
[TBL] [Abstract][Full Text] [Related]
37. Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth.
Elson DJ; Nguyen BD; Korjeff NA; Wilferd SF; Puig-Sanvicens V; Sang Jang H; Bernales S; Chakravarty S; Belmar S; Ureta G; Finlay D; Plaisier CL; Kolluri SK
Biochem Pharmacol; 2023 Sep; 215():115706. PubMed ID: 37506922
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
[TBL] [Abstract][Full Text] [Related]
39. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
[TBL] [Abstract][Full Text] [Related]
40. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
Döhr O; Vogel C; Abel J
Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
